Oral Azacitidine and Lenalidomide Combinations in Myelodysplastic Syndromes
1 Views
administrator
07/04/23
Harry P. Erba, MD, PhD, summarizes clinical studies presented at the 2013 ASH Annual Meeting focused on the administration of oral azacitidine and combination therapies for patients with myelodysplastic syndromes.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/mds-cml
-
Category
Show more
Facebook Comments
No comments found